Operating in foreign countries, especially in emerging markets, can expose your company to additional risks related to unpredictable
foreign government acts or political events.
Not exact matches
The
government of Prime Minister Pierre Trudeau introduced the
Foreign Investment Review
Act (FIRA) in 1973, forming a federal agency to advise on the respective benefits and hazards of particular transactions.
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in
foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other
foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or
acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and
foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other
foreign anti-bribery laws such as the
Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other
Foreign Corrupt Practices
Act and the United Kingdom Bribery
Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs
Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other
governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in
foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other
foreign current exchange rates, impositions of tariffs or embargoes, compliance with
foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other
foreign laws, and domestic and
foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other
foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Not only did the
government fail to ease
foreign ownership and entry restrictions in the key sectors of telecom and air transport, it rendered the Investment Canada
Act's
foreign investment review process more uncertain and less transparent.
First, of course, is the Logan
Act, which prohibits private individuals conducting negotiations on behalf of the US
government with
foreign governments,» Deitz said.
Google will, however, work with the
government when
Foreign Intelligence Surveillance
Act requests are delivered to the company.
A U.S. takeover is the best way to ensure MDA's space division gains future work, because the Buy America
Act and post-9 / 11 restrictions make it harder for
foreign companies to win contracts from the
government and the Pentagon.
President Donald Trump on Thursday criticized the
Foreign Intelligence Surveillance
Act hours after the White House press secretary released a statement saying the administration supported the law and opposed an amendment that would impose limits on the
government's surveillance authority.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and
government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care
Act or other
government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the
foreign exchange rate of the U.S. dollar that may cause an unfavorable
foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Any
foreign institutions that hold Markle's assets would also have to disclose that to the U.S. government under the Foreign Account Tax Compliance Act, or
foreign institutions that hold Markle's assets would also have to disclose that to the U.S.
government under the
Foreign Account Tax Compliance Act, or
Foreign Account Tax Compliance
Act, or FATCA.
«The US
government acted as police force (identifying the
foreign government's crime), prosecutor (making the legal arguments), jury (ruling on the evidence), and judge (sentencing the foreigner to US retaliatory punishment),» Chad Bown, a senior fellow at the pro-free trade Peterson Institute for International Economics, wrote in a memo about Section 301's history earlier in August.
The United States Securities and Exchange Commission (SEC) has adopted rules, mandated by the Dodd - Frank
Act, requiring resource companies to disclose certain payments made to the U.S.
government or
foreign governments (including subnational
governments).
The Honest Ads
Act would require social media companies to disclose what groups are running political advertisements and make «reasonable efforts» to ensure
foreign governments and agents aren't purchasing ads on their platforms.
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of
government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in
government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including
foreign currency movements;
acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
If this wasn't enough to get environmentalist in an uproar the
government then proposed changes to the income tax
act that would require that that charities disclose
foreign sources of funds and demonstrate that the organization satisfied the 10 per cent rule for political activities.
Not later than 270 days after the date of enactment of the Dodd - Frank Wall Street Reform and Consumer Protection
Act, the Commission shall issue final rules that require each resource extraction issuer to include in an annual report of the resource extraction issuer information relating to any payment made by the resource extraction issuer, a subsidiary of the resource extraction issuer, or an entity under the control of the resource extraction issuer to a
foreign government or the Federal Government for the purpose of the commercial development of oil, natural gas, or m
government or the Federal
Government for the purpose of the commercial development of oil, natural gas, or m
Government for the purpose of the commercial development of oil, natural gas, or minerals...
The Honest Ads
Act would require social media companies to disclose which groups are running political advertisements and make reasonable efforts to ensure
foreign governments and agents aren't purchasing ads on their platforms.
For example, from: 1) the replenishment of
foreign exchange buffers large enough to protect the economy against a protracted shock; 2) a significant reduction in
government debt metrics; 3) a successful diversification of the economy and
government revenues that will become less dependent on oil receipts; 4) continued improvements in governance and institutional strength which
act as long — term constraints on Angola's rating.
The content of the
act allows the United States to conclude agreements with
foreign governments.
A judge from the
Foreign Intelligence Surveillance Act Court has to give the FBI permission if it wants to spy on a US citizen it thinks might be working with a foreign gove
Foreign Intelligence Surveillance
Act Court has to give the FBI permission if it wants to spy on a US citizen it thinks might be working with a
foreign gove
foreign government.
The most famous example of this is the Buy American
Act (BAA), which serves as the general prohibition against the United States
government procurement of
foreign items.
The ISDS chapter in a trade agreement of a country where you are considering doing business or investing could
act as a shield against any arbitrary
foreign government measures that would negatively impact your business.
When I ran a global trade and financial company out of Southeast Asia, I was continually dogged by
government rules... especially the U.S.
Foreign Corrupt Practices
Act.
That is a tough balancing
act for a country that relies on
foreign capital to finance its current account deficit - which has doubled to $ 55 billion over the last few years, according to Citigroup - but where the
government says three in five children are stunted from malnutrition.
Hey Bill Deacon, US citizens
acting as agents of a
foreign government are required to register as such.
We
act as though our
government is headed by King George III, a
foreign power, not an instrument of national purpose.
The
government's move can be traced back to 2011, when it changed its
Foreign Contribution Regulation
Act so that it could regulate NGOs it disagrees with philosophically, Mellado said.
[If a
foreign government is your opponent, then you should first offer justice and peace, but if this is refused then defend yourself by force against force...] And in such a war it is a Christian
act and an
act of love confidently to kill, rob, and pillage the enemy, and to do everything that can injure him until one has conquered him according to the methods of war.13
The main purpose of the
Act is to forbid private citizens from «doing diplomacy» with
foreign governments and to not prohibit discussion or sharing of opinions.
I've tracked down a Logan
Act, which prohibits NEGOTIATION with
foreign governments having a dispute with the United States.
There needs to be an «intent to influence the measures or conduct of any
foreign government» as quoted from the Logan
Act.
23 March 2010 — OPPOSITION: SHADOW MINISTERIAL VISITS Question: To ask Her Majesty's
Government whether any information has been released following a request under the Freedom of Information
Act 2000 to the
Foreign and Commonwealth Office relating to the visit of the Shadow
Foreign Secretary, William Hague, to Cuba in March 2009; if so, to whom; and when.
«The Federal Election Campaign
Act's prohibition on
foreign contributions is the broadest prohibition in the entire statute,» said Brett Kappel, a partner in the
government affairs and public policy practice of the law firm Ackerman in Washington, D.C.
«The
act only applies to conduct that is designed to «defeat the measures of the United States» or influence the conduct of
foreign governments,» Vladeck said.
The
foreign exchange Retention Agreement of 2006,
Act 723 which was passed by the then
government legalized capital flight and repatriation of mining proceeds by multinational mining companies in Ghana.
«Americans have a right to know who is
acting in the United States to influence the U.S.
government or public on behalf of
foreign principals,» said
acting Assistant Attorney General Dana Boente.
According to an article by Ria Novsti the Russian
Foreign Ministry claims that the recently announced US Financial Aid to the new Kiev
Government is illegal because the 1961 Foreign Assistance Act prohibits financial assistance to the government of any state whose legally elected president was overthrown as a result of a military coup or an unlawful
Government is illegal because the 1961
Foreign Assistance
Act prohibits financial assistance to the
government of any state whose legally elected president was overthrown as a result of a military coup or an unlawful
government of any state whose legally elected president was overthrown as a result of a military coup or an unlawful decision.
At the time, it was part of a civil rights agenda being set by the then Labour opposition, which included such things as the Human Right
Act, and a (failed) «Ethical
Foreign Policy» and was in stark contrast to the authoritarian approach of the then Conservative
Government; Michael Howard's support for ID cards and Ken Clarke using PII Cetificates in the Matrix Churchill case spring to mind.
The letter Patino received was being played down by the
Foreign Office this morning, but it does mention the Diplomatic and Consular Premises
Act 1987, which allows the
government to revoke diplomatic status of an embassy on UK soil.
Shadow
foreign minister David Liddington said yesterday the
government should have made the decision to
act against Zimbabwe sooner.
The comments reiterate deeply - held Conservative opposition to the idea, with some reports suggesting shadow
foreign secretary William Hague said it would be «a hostile
act» against an incoming Tory
government for the EU to select him.
According to the
Foreign Office, the
Government is still looking into what legislation needs to be amended, but this will include the Bill of Rights, the Coronation Oath
Act, the
Act of Settlement, the
Act of Union with Scotland, the Accession Declaration
Act, Princess Sophia's Precedence
Act, Royal Marriages
Act, the Union with Ireland
Act and the Regency
Act.
http://ghanapoliticsonline.com On January 5, 2016, the Deputy Chief of Mission / Chargé d'Affaires of the US Embassy in Ghana, then
acting as Chief of Mission, Melinda Tabler - Stone, called on Nana Akufo - Addo at his Nima residence to inform him, with the consent of the Minister for
Foreign Affairs, about the impending arrival into the country of two ex-Guantanamo Bay detainees, Mahmud Umar Muhammad Bin Atef and Khalid Muhammad Salih Al Dhuby, as a result of discussions between the US and Ghana
governments.
The position of the Federal
Government is that in view of the fact that Cameroon has been a major key player in the war against insurgency and the involvement of Cameroon in fighting for the stability of Nigeria, it will be out of the
foreign policy context of Nigeria to abandon Cameroon and the
acting president directed me — and I have communicated appropriately that if the only vote that will come to Hayatou will be from Nigeria, Nigeria should stand with Hayatou.»
Foreign affairs are of course the responsibility of the UK
Government, and in dealing with them we
act in the interests of all parts of the United Kingdom.
The statement signed by its Ranking Member on Parliament's
Foreign Affairs Committee, Samuel Okudzeto Ablakwa, further said «The loud silence of Ghana's
Foreign Minister, Ms. Shirley Ayorkor Botchwey and the
Government led by President Akufo - Addo especially in the face of some reprehensible support from sections of the NPP led by its
Acting Chairman Freddie Blay, is most troubling as it has the tendency to convey a tacit approval of the egregious sins of their chief diplomat in South Africa.»
Thus far, the loud silence of Ghana's
Foreign Minister, Hon.. Ms. Shirley Ayorkor Botchwey and the
Government led by President Akufo - Addo especially in the face of some reprehensible support from sections of the NPP led by its
Acting Chairman Freddie Blay is most troubling as it has the tendency to convey a tacit approval of the egregious sins of their chief diplomat in South Africa.
When I passed a copy of the article to Douglas Hogg, the
Foreign Office minister, he was quick to point out, with some justice, that the
government can not be expected to
act single - handedly to stop the tropics drying out, but that his department was using its influence within the international community «to try to speed up progress».
Needless to say North Korea is not impressed and Sony has reportedly made changes given a spokesman for North Korea's
Foreign Ministry said in state media that if the US
government does not block the release of the movie, it would be considered an «
act of war».
Yet this as much a film about eco-terrorism as Meek's Cutoff was a film about the American gold rush, operating as a rich, sui generic parable for any and all
acts of violence, whether micro scale such as the one chronicled here, or those sanctioned by
governments with a view to being executed in
foreign climes.